FDA News Analysis
🇪🇺 EMAExpert commentary and market intelligence for pharma strategy teams
Showing 1–12 of 17 articles
AI in Drug Discovery Examples: What’s Changed Beyond Early Use Cases
FDA · 7 min
Dr. Elena RossiFederal Court Litigation on Reproductive Health: Rare Disease Implications
FDA · rare disease · 5 min
Dr. Elena RossiFDA Voucher Program Pause Urged: Rare Disease Policy Analysis
FDA · rare disease · 5 min
Dr. Elena RossiKaléo's Initiative on Allergy Awareness: Amplifying Patient Stories
FDA · allergy · 5 min
Dr. Elena RossiCellectar Biosciences (CLRB) FDA Approvals, PDUFA Dates & Drug Alerts 2026
FDA · 5 min
Dr. Elena RossiTracy Beth Høeg's Departure: Implications for Pharma BD and Regulatory Teams
FDA · 6 min
Dr. Elena RossiAbbVie Plans Layoffs: Implications for the Pharma Industry
FDA · 6 min
Dr. Elena RossiQuoin Pharmaceuticals Aims for First Peeling Skin Syndrome Trial with FDA IND Submission
FDA · 9 min
Dr. Elena RossiASCO26: AstraZeneca's Camizestrant Data Aims to Sway FDA Approval
FDA · 8 min
Dr. Elena RossiOS Therapies' OST-HER2 Nears FDA Accelerated Approval for Osteosarcoma Amidst ASCO Data Presentation
FDA · osteosarcoma · 8 min
Dr. Elena RossiFDA Approves AstraZeneca's Imfinzi-BCG Combination for High-Risk NMIBC
FDA · NMIBC · 8 min
Dr. Elena RossiImmunityBio's Anktiva Expansion: Navigating FDA Decision Dates and Regulatory Hurdles
FDA · bladder cancer · 9 min
Dr. Elena RossiExplore intelligence